Status: Recruiting
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
A Phase 1/1B Study of ST-01156 in Patients with Advanced Solid Malignancies
Participants needed: 171
Trial details
Phase: Phase 1Age: 16+Biological sex: AllType: InterventionalSponsor: SEED Therapeutics, Inc.Updated: Jun 2, 2026Locations: 6
Eligibility criteria
Age ≥ 18 years on the day of signing the consent form, except for adolescents wi... [+4]
Has received prior radiotherapy within 2 weeks of treatment. [+5]